DWD 81.06(4)(f)1.a.
a. Maximum treatment frequency is 5 times for the first week decreasing to 3 times per week for the next 2 weeks and decreasing in frequency after the third week.
DWD 81.06(4)(f)2.
2. `Guidelines for unsupervised exercise.' Unsupervised exercise shall be provided in the least intensive setting appropriate to the goals of the exercise program and may supplement or follow the period of supervised exercise. All of the following guidelines apply to unsupervised exercise:
DWD 81.06(4)(f)2.a.
a. Maximum treatment frequency is up to 3 visits for instruction and monitoring.
DWD 81.06(5)(a)(a) Injection modalities are necessary as set forth in
pars. (b) to
(d). A health care provider's use of injections may extend past the 12-week limit on passive treatment modalities so long as the maximum treatment for injections is not exceeded.
DWD 81.06(5)(b)
(b) For purposes of this subsection, “therapeutic injections" include injections of trigger points, facet joints, facet nerves, sacroiliac joints, sympathetic nerves, epidurals, nerve roots, and peripheral nerves. Therapeutic injections may only be given in conjunction with active treatment modalities directed to the same anatomical site.
DWD 81.06(5)(b)1.
1. All of the following guidelines apply to trigger point injections:
DWD 81.06(5)(b)1.b.
b. Maximum treatment frequency is once per week to any one site if there is a positive response to the first injection at that site. If subsequent injections at that site demonstrate diminishing control of symptoms or fail to facilitate objective functional gains, then trigger point injections shall be redirected to other areas or discontinued. No more than 3 injections to different sites per patient visit may be given.
DWD 81.06(5)(b)2.
2. All of the following guidelines apply to sacroiliac joint injections:
DWD 81.06(5)(b)2.b.
b. Maximum treatment frequency may permit repeat injection 2 weeks after the previous injection if there is a positive response to the first injection. Only 2 injections per patient visit.
DWD 81.06(5)(b)3.
3. All of the following guidelines apply to facet joint or nerve injections:
DWD 81.06(5)(b)3.b.
b. Maximum treatment frequency is once every 2 weeks to any one site if there is a positive response to the first injection. If subsequent injections demonstrate diminishing control of symptoms or fail to facilitate objective functional gains, then injections shall be discontinued. Only 3 injections to different sites per patient visit.
DWD 81.06(5)(b)4.b.
b. Maximum treatment frequency may permit repeat injection 2 weeks after the previous injection if there is a positive response to the first injection. Only 3 injections to different sites per patient visit.
DWD 81.06(5)(b)4.c.
c. Maximum treatment is 2 injections to any one site. Maximum treatment is 2 injections to any one site.
DWD 81.06(5)(b)5.b.
b. Maximum treatment frequency is once every 2 weeks if there is a positive response to the first injection. If subsequent injections demonstrate diminishing control of symptoms or fail to facilitate objective functional gains, then injections should be discontinued. Only one injection per patient visit.
DWD 81.06(5)(c)
(c) For purposes of this paragraph, “lytic or sclerosing injections" include radio frequency denervation of the facet joints. These injections may only be given in conjunction with active treatment modalities directed to the same anatomical site. All of the following guidelines apply to lytic or sclerosing injections:
DWD 81.06(5)(c)2.
2. Maximum treatment frequency may repeat 4 times per year or once every 3 months for any site.
DWD 81.06(5)(d)
(d) Prolotherapy and botulinum toxin injections are not necessary in the treatment of low back problems.
DWD 81.06(6)
(6) Surgery, including decompression procedures and arthrodesis. DWD 81.06(6)(b)
(b) In order to optimize the beneficial effect of surgery, postoperative therapy with active and passive treatment modalities may be provided, even if these modalities had been used in the preoperative treatment of the condition. In the postoperative period, the maximum treatment duration with passive treatment modalities in a clinical setting from the initiation of the first passive modality used, except bedrest or bracing, is as follows:
DWD 81.06(6)(b)1.
1. Eight weeks following lumbar decompression or implantation of a spinal cord stimulator or intrathecal drug delivery system.
DWD 81.06(6)(d)
(d) The surgical therapies in
subds. 1. and
2. have very limited application and require a personality or psychosocial evaluation that indicates the patient is likely to benefit from the treatment:
DWD 81.06(6)(d)1.
1. Spinal cord stimulator may be necessary for a patient who has neuropathic pain and has had a favorable response to a trial screening period.
DWD 81.06(6)(d)2.
2. Intrathecal drug delivery system may be necessary for a patient who has somatic or neuropathic pain and has had a favorable response to a trial screening period.
DWD 81.06(7)
(7) Chronic management. Chronic management of low back pain shall be provided according to the guidelines of
s. DWD 81.13.
DWD 81.06(8)(a)(a) A health care provider may direct the use of durable medical equipment in any of the following:
DWD 81.06(8)(a)2.
2. For patients using electrical muscle stimulation or mechanical traction devices at home, the device and any required supplies are necessary within the guidelines of
sub. (3) (e) and
(f).
DWD 81.06(8)(a)3.
3. Exercise equipment for home use, including bicycles, treadmills, and stairclimbers, are necessary only as part of an approved chronic management program. This equipment is not necessary during initial nonsurgical care or during reevaluation and surgical therapy. If the employer has an appropriate exercise facility on its premises with the prescribed equipment, the insurer may mandate use of that facility instead of authorizing purchase of the equipment for home use.
DWD 81.06(8)(a)3.a.
a. `Indications.' The patient is deconditioned and requires reconditioning that may be accomplished only with the use of the prescribed exercise equipment. A health care provider shall document specific reasons why the exercise equipment is necessary and may not be replaced with other activities.
DWD 81.06(8)(a)3.b.
b. `Requirements.' The use of the equipment shall have specific goals and there shall be a specific set of prescribed activities.
DWD 81.06(8)(b)
(b) All of the following durable medical equipment is not necessary for home use for low back conditions:
DWD 81.06(8)(b)1.
1. Whirlpools, Jacuzzis, hot tubs, and special bath or shower attachments.
DWD 81.06(9)
(9) Evaluation of treatment by health care provider. DWD 81.06(9)(a)(a) A health care provider shall evaluate at each visit whether the treatment is medically necessary and shall evaluate whether initial nonsurgical treatment is effective according to
pars. (b) to
(e). No later than the time for treatment response established for the specific modality in
subs. (3) to
(5), a health care provider shall evaluate whether the passive, active, injection, or medication treatment modality is resulting in progressive improvement in
pars. (b) to
(e).
DWD 81.06(9)(b)
(b) The patient's subjective complaints of pain or disability are progressively improving, as evidenced by documentation in the medical record of decreased distribution, frequency, or intensity of symptoms.
DWD 81.06(9)(c)
(c) The objective clinical findings are progressively improving, as evidenced by documentation in the medical record of resolution or objectively measured improvement in physical signs of the injury.
DWD 81.06(9)(d)
(d) The patient's functional status, especially vocational activity, is progressively improving, as evidenced by documentation in the medical record or documentation of work ability involving less restrictive limitations on activity.
DWD 81.06(9)(e)
(e) If there is not progressive improvement in at least 2 criteria specified in
pars. (b) to
(d), the modality shall be discontinued or significantly modified or a health care provider shall reconsider the diagnosis. The evaluation of the effectiveness of the treatment modality may be delegated to another health care provider.
DWD 81.06(10)(a)(a) Prescription of controlled substance medications under
ch. 450, Stats., including opioids and narcotics, are indicated primarily for the treatment of severe acute pain. These medications are not recommended in the treatment of patients with persistent low back pain.
DWD 81.06(10)(b)
(b) Patients with radicular pain may require longer periods of treatment.
DWD 81.06(10)(c)
(c) A health care provider shall document the rationale for the use of any scheduled medication. Treatment with nonnarcotic medication may be appropriate during any phase of treatment and intermittently after all other treatment has been discontinued. The prescribing health care provider shall determine that ongoing medication is effective treatment for the patient's condition.
DWD 81.06(11)
(11) Specific treatment guidelines for regional low back pain. DWD 81.06(11)(a)(a) A health care provider shall use initial nonsurgical treatment as the first phase of treatment for all patients with regional low back pain under
sub. (1) (b) 1.
DWD 81.06(11)(a)1.
1. The passive, active, injection, durable medical equipment, and medication treatment modalities and procedures in
subs. (3),
(4),
(5),
(8), and
(10) may be used in sequence or simultaneously during the period of initial nonsurgical management, depending on the severity of the condition.
DWD 81.06(11)(a)2.
2. The only therapeutic injections necessary for patients with regional low back pain are trigger point injections, facet joint injections, facet nerve injections, sacroiliac joint injections, and epidural blocks, and their use shall meet the guidelines of
sub. (5).
DWD 81.06(11)(a)3.
3. After the first week of treatment, initial nonsurgical treatment shall at all times contain active treatment modalities according to the guidelines in
sub. (4).
DWD 81.06(11)(a)4.
4. Initial nonsurgical treatment shall be provided in the least intensive setting consistent with quality health care practices.
DWD 81.06(11)(a)5.
5. Except as otherwise specified in
sub. (3), passive treatment modalities in a clinic setting or requiring attendance by a health care provider are not necessary beyond 12 weeks after any passive modality other than bedrest or bracing is first initiated.
DWD 81.06(11)(b)
(b) Surgical evaluation or chronic management is necessary if the patient continues with symptoms and physical findings after the course of initial nonsurgical care and if the patient's condition prevents the resumption of the regular activities of daily life, including regular vocational activities. The purpose of surgical evaluation is to determine whether surgery is necessary in the treatment of a patient who has failed to recover with initial nonsurgical care. If the patient is not a surgical candidate, then chronic management is necessary.
DWD 81.06(11)(b)1.
1. Surgical evaluation, if necessary, may begin as soon as 8 weeks after, but shall begin no later than 12 weeks after, beginning initial nonsurgical management. An initial recommendation or decision against surgery may not preclude surgery at a later date.
DWD 81.06(11)(b)2.
2. Surgical evaluation may include the use of appropriate medical imaging techniques. The imaging technique shall be chosen on the basis of the suspected etiology of the patient's condition but a health care provider shall follow the guidelines in
s. DWD 81.05. Medical imaging studies that do not meet these guidelines are not necessary.
DWD 81.06(11)(b)3.
3. Surgical evaluation may also include diagnostic blocks and injections. These blocks and injections are only necessary if their use is consistent with the guidelines of
sub. (1) (j).
DWD 81.06(11)(b)4.
4. Surgical evaluation may also include personality or psychosocial evaluation, consistent with the guidelines of
sub. (1) (i).
DWD 81.06(11)(b)5.
5. Consultation with other health care providers may be appropriate as part of the surgical evaluation. The need for consultation and the choice of consultant will be determined by the findings on medical imaging, diagnostic analgesic blocks, and injections, if performed, and the patient's ongoing subjective complaints and physical findings.
DWD 81.06(11)(b)6.
6. The only surgical procedures necessary for patients with regional low back pain are decompression of a lumbar nerve root or lumbar arthrodesis, with or without instrumentation, which shall meet the guidelines of
sub. (6) and
s. DWD 81.12 (1). For patients with failed back surgery, spinal cord stimulators or intrathecal drug delivery systems may be necessary and consistent with
sub. (6) (d).
DWD 81.06(11)(b)6.a.
a. If surgery is necessary, it shall be offered to the patient as soon as possible. If the patient agrees to the proposed surgery, it shall be performed as expeditiously as possible consistent with sound medical practice.
DWD 81.06(11)(b)6.b.
b. If surgery is not necessary, or if the patient does not wish to proceed with surgery, then the patient is a candidate for chronic management under the guidelines in
s. DWD 81.13.
DWD 81.06(11)(c)
(c) If the patient continues with symptoms and objective physical findings after surgical therapy has been rendered or the patient refuses surgical therapy or the patient was not a candidate for surgical therapy, and if the patient's condition prevents the resumption of the regular activities of daily life including regular vocational activities, then the patient may be a candidate for chronic management that shall be provided under the guidelines in
s. DWD 81.13.
DWD 81.06(12)
(12) Specific treatment guidelines for radicular pain, with or without regional low back pain, with no or static neurologic deficits. DWD 81.06(12)(a)(a) Initial nonsurgical treatment is appropriate for all patients with radicular pain, with or without regional low back pain, with no or static neurologic deficits under
sub. (1) (b) 2., and shall be the first phase of treatment. It shall be provided within the guidelines of
sub. (11) (a), with the following modifications: Epidural blocks and nerve root and peripheral nerve blocks are the only therapeutic injections necessary for patients with radicular pain only. If there is a component of regional low back pain, therapeutic facet joint injections, facet nerve injections, trigger point injections, and sacroiliac injections may also be necessary.
DWD 81.06(12)(b)
(b) Surgical evaluation or chronic management is necessary if the patient continues with symptoms and physical findings after the course of initial nonsurgical care and if the patient's condition prevents the resumption of the regular activities of daily life, including regular vocational activities. It shall be provided within the guidelines of
sub. (11) (b).
DWD 81.06(12)(c)
(c) If the patient continues with symptoms and objective physical findings after surgical therapy has been rendered or the patient refused surgical therapy or the patient was not a candidate for surgical therapy, and if the patient's condition prevents the resumption of the regular activities of daily life including regular vocational activities, then the patient may be a candidate for chronic management. Any course or program of chronic management for patients with radicular pain, with or without regional low back pain, with static neurologic deficits shall be provided under the guidelines of
s. DWD 81.13.
DWD 81.06(13)
(13) Specific treatment guidelines for cauda equina syndrome and for radicular pain, with or without regional low back pain, with progressive neurologic deficits. DWD 81.06(13)(a)(a) Patients with cauda equina syndrome or with radicular pain, with or without regional low back pain, with progressive neurologic deficits may require immediate or emergency surgical evaluation at any time during the course of the overall treatment. The decision to proceed with surgical evaluation is made by a health care provider based on the type of neurologic changes observed, the severity of the changes, the rate of progression of the changes, and the response to any initial nonsurgical treatments. Surgery, if necessary, may be performed at any time during the course of treatment. Surgical evaluation and surgery shall be provided within the guidelines of
sub. (11) (b), except that surgical evaluation and surgical therapy may begin at any time.
DWD 81.06(13)(b)
(b) If a health care provider decides to proceed with a course of initial nonsurgical care for a patient with radicular pain with progressive neurologic changes, it shall follow the guidelines of
sub. (12) (a).
DWD 81.06(13)(c)
(c) If the patient continues with symptoms and objective physical findings after surgical therapy has been rendered or the patient refuses surgical therapy or the patient was not a candidate for surgical therapy, and if the patient's condition prevents the resumption of the regular activities of daily life including regular vocational activities, then the patient may be a candidate for chronic management. Any course or program of chronic management for patients with radicular pain, with or without regional low back pain, with foot drop or progressive neurologic changes at first presentation shall be provided under the guidelines of
s. DWD 81.13.
DWD 81.06 History
History: CR 07-019: cr. Register October 2007 No. 622, eff. 11-1-07.
